Nebid (Testosterone Undecanoate)

• Nebid is used in the management of conditions related to insufficient endogenous testosterone production.
• Male hypogonadism: restores physiological testosterone levels and reduces fatigue, loss of libido, and muscle weakness.
• Testosterone deficiency: improves energy, mood, and bone density in men with low serum testosterone.
• Hormone replacement therapy in men: maintains secondary sexual characteristics and supports overall metabolic health.

• Testosterone undecanoate acts as a prodrug that, after intramuscular injection, is hydrolyzed to testosterone. The liberated testosterone binds intracellular androgen receptors, modulating gene transcription that promotes anabolic processes and suppresses catabolic pathways, thereby restoring androgenic activity throughout target tissues.

Nebid may be associated with a range of adverse reactions following administration.

Common Side Effects

• Injection site pain: mild to moderate discomfort at the injection site.
• Acne or oily skin: increased sebum production leading to breakouts.
• Fluid retention: mild edema, particularly in the lower extremities.
• Mood changes: irritability or increased aggression.
• Elevated hematocrit: rise in red blood cell concentration.
• Decreased HDL cholesterol: reduction in high‑density lipoprotein levels.

Serious or Rare Side Effects

• Cardiovascular events: increased risk of thrombosis or myocardial infarction.
• Hepatotoxicity: signs of liver dysfunction such as jaundice.
• Prostatic enlargement: worsening of benign prostatic hyperplasia symptoms.
• Severe allergic reaction: anaphylaxis with rash, swelling, or respiratory distress.

• Nebid requires careful consideration of patient history and monitoring.
• Screen for cardiovascular disease: assess risk factors before initiating therapy.
• Monitor hematocrit and lipid profile: periodic blood tests to detect abnormalities.
• Evaluate prostate health: conduct digital rectal exam and PSA testing.
• Avoid use in patients with known hypersensitivity: discontinue if allergic reactions occur.
• Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Nebid can interact with other medications, influencing efficacy or safety.

Major Interactions (Avoid)

• Anticoagulants (e.g., warfarin): increased bleeding risk.
• Insulin or oral hypoglycemics: may enhance glucose‑lowering effects.
• 5α‑reductase inhibitors (e.g., finasteride): altered androgen metabolism.

Moderate Interactions (Monitor Closely)

• CYP3A4 inhibitors (e.g., ketoconazole): may raise testosterone levels.
• Glucocorticoids: potential additive effects on fluid retention.
• Antihypertensives: possible attenuation of blood pressure control.